TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma
Clinical trial NCT00243763 · TERMINATED
Trial details
- NCT number
- NCT00243763
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.